IRINA SANBERG: Open Payments
NPI 1952353492 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 21 payments from 11 companies in 2025. Trend: 2023 $962 · 2024 $772 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $156 |
| Boston Scientific Corporation | 1 | $153 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| BridgeBio Pharma, Inc. | 1 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| Alnylam Pharmaceuticals Inc. | 1 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Novo Nordisk Inc | 2 | $36 |
| PFIZER INC. | 1 | $21 |
Products named: REPATHA, WATCHMAN, EVKEEZA, CAMZYOS, Attruby, LEQVIO, AMVUTTRA, FARXIGA.
Industry payments across NY — which companies pay providers there.
